Ruchi Saxena

863 total citations
31 papers, 656 citations indexed

About

Ruchi Saxena is a scholar working on Molecular Biology, Genetics and Immunology. According to data from OpenAlex, Ruchi Saxena has authored 31 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Genetics and 9 papers in Immunology. Recurrent topics in Ruchi Saxena's work include Estrogen and related hormone effects (9 papers), Immunotherapy and Immune Responses (5 papers) and Complement system in diseases (5 papers). Ruchi Saxena is often cited by papers focused on Estrogen and related hormone effects (9 papers), Immunotherapy and Immune Responses (5 papers) and Complement system in diseases (5 papers). Ruchi Saxena collaborates with scholars based in India, United States and Ireland. Ruchi Saxena's co-authors include Anila Dwivedi, Iram Fatima, Vishal Chandra, Pushplata Sankhwar, You‐Wen He, Atul Kumar, Murli Manohar, Garima Gupta, Rituraj Konwar and Sudheer Kumar Singh and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ruchi Saxena

30 papers receiving 640 citations

Peers

Ruchi Saxena
Martin Berger Germany
Mamoru Nukatsuka Japan
Bo Jiao China
Naoki Wakimoto Japan
Ivo Nnane United States
Crescent R. Isham United States
Hong Yuen Wong United States
Alison D. Findlay Australia
Kaori Endo‐Umeda Japan
Martin Berger Germany
Ruchi Saxena
Citations per year, relative to Ruchi Saxena Ruchi Saxena (= 1×) peers Martin Berger

Countries citing papers authored by Ruchi Saxena

Since Specialization
Citations

This map shows the geographic impact of Ruchi Saxena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruchi Saxena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruchi Saxena more than expected).

Fields of papers citing papers by Ruchi Saxena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruchi Saxena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruchi Saxena. The network helps show where Ruchi Saxena may publish in the future.

Co-authorship network of co-authors of Ruchi Saxena

This figure shows the co-authorship network connecting the top 25 collaborators of Ruchi Saxena. A scholar is included among the top collaborators of Ruchi Saxena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruchi Saxena. Ruchi Saxena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Clarke, Jeffrey, George R. Simon, Hirva Mamdani, et al.. (2025). Complement factor H targeting antibody GT103 in refractory non-small cell lung cancer: a phase 1b dose escalation trial. Nature Communications. 16(1). 93–93. 7 indexed citations
2.
Saxena, Ruchi, Elizabeth B. Gottlin, Michael J. Campa, You‐Wen He, & Edward F. Patz. (2025). Complement regulators as novel targets for anti-cancer therapy: A comprehensive review. Seminars in Immunology. 77. 101931–101931. 9 indexed citations
3.
Saxena, Ruchi, Catherine F. Welsh, & You‐Wen He. (2024). Targeting regulated cell death pathways in cancers for effective treatment: a comprehensive review. Frontiers in Cell and Developmental Biology. 12. 1462339–1462339. 7 indexed citations
4.
Saxena, Ruchi, Elizabeth B. Gottlin, Michael J. Campa, et al.. (2024). Complement factor H: a novel innate immune checkpoint in cancer immunotherapy. Frontiers in Cell and Developmental Biology. 12. 1302490–1302490. 16 indexed citations
5.
Saxena, Ruchi, et al.. (2023). Antitumor Immune Mechanisms of the Anti-Complement Factor H Antibody GT103. Molecular Cancer Therapeutics. 22(6). 778–789. 16 indexed citations
6.
Srivastava, Kuldeep, et al.. (2022). Correlation of Menopausal Status with Body Composition and Abdominal Fat Distribution. SHILAP Revista de lepidopterología. 13(4). 203–206. 2 indexed citations
7.
Chen, Chun-Hau, Swati S. Bhasin, Ruchi Saxena, et al.. (2019). Study of Cathepsin B inhibition in VEGFR TKI treated human renal cell carcinoma xenografts. Oncogenesis. 8(3). 15–15. 20 indexed citations
8.
Raghuvanshi, Ashutosh, Amit Kumar, Abdul Malik Tyagi, et al.. (2017). 3-Piperidylethoxypterocarpan: A potential bone anabolic agent that improves bone quality and restores trabecular micro-architecture in ovariectomized osteopenic rats. Molecular and Cellular Endocrinology. 448. 41–54. 5 indexed citations
9.
Saxena, Ruchi, Garima Gupta, Murli Manohar, et al.. (2015). Spiro-oxindole derivative 5-chloro-4′,5′-diphenyl-3′-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2′-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function. The International Journal of Biochemistry & Cell Biology. 70. 105–117. 16 indexed citations
10.
Kumar, Atul, Garima Gupta, Ruchi Saxena, et al.. (2014). Design and synthesis of new bioisosteres of spirooxindoles (MI-63/219) as anti-breast cancer agents. Bioorganic & Medicinal Chemistry. 23(4). 839–848. 52 indexed citations
11.
12.
13.
Manohar, Murli, Iram Fatima, Ruchi Saxena, et al.. (2012). (−)-Epigallocatechin-3-gallate induces apoptosis in human endometrial adenocarcinoma cells via ROS generation and p38 MAP kinase activation. The Journal of Nutritional Biochemistry. 24(6). 940–947. 57 indexed citations
14.
Fatima, Iram, Vishal Chandra, Ruchi Saxena, et al.. (2011). 2,3-Diaryl-2H-1-benzopyran derivatives interfere with classical and non-classical estrogen receptor signaling pathways, inhibit Akt activation and induce apoptosis in human endometrial cancer cells. Molecular and Cellular Endocrinology. 348(1). 198–210. 15 indexed citations
15.
Chandra, Vishal, Iram Fatima, Ruchi Saxena, et al.. (2011). Apoptosis induction and inhibition of hyperplasia formation by 2-[piperidinoethoxyphenyl]-3-[4-hydroxyphenyl]-2H-benzo(b)pyran in rat uterus. American Journal of Obstetrics and Gynecology. 205(4). 362.e1–362.e11. 12 indexed citations
16.
Saxena, Ruchi & Anila Dwivedi. (2010). ErbB family receptor inhibitors as therapeutic agents in breast cancer: Current status and future clinical perspective. Medicinal Research Reviews. 32(1). 166–215. 67 indexed citations
17.
Daverey, Amita, Ruchi Saxena, Shikha Tewari, Sudhir K. Goel, & Anila Dwivedi. (2009). Expression of estrogen receptor co-regulators SRC-1, RIP140 and NCoR and their interaction with estrogen receptor in rat uterus, under the influence of ormeloxifene. The Journal of Steroid Biochemistry and Molecular Biology. 116(1-2). 93–101. 11 indexed citations
18.
Bhat, Amilal, et al.. (2009). Female hypospadias with vaginal stones: A rare congenital anomaly. Journal of Pediatric Urology. 6(1). 70–74. 10 indexed citations
19.
Suseela, M. R., S. Sinha, Sudheer Kumar Singh, & Ruchi Saxena. (2002). Accumulation of Chromium and Scanning Electron Microscopic Studies in Scirpus lacustris L. Treated with Metal and Tannery Effluent. Bulletin of Environmental Contamination and Toxicology. 68(4). 540–548. 36 indexed citations
20.
Ho, Carolyn Y., Brith Otterud, Tena Varvil, et al.. (1996). Linkage of a familial platelet disorder with a propensity to develop myeloid malignancies to human chromosome 21q22.1-22.2. Blood. 87(12). 5218–5224. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martin Berger Breakdown of academic impact, for papers by Mamoru Nukatsuka Breakdown of academic impact, for papers by Bo Jiao Breakdown of academic impact, for papers by Naoki Wakimoto Breakdown of academic impact, for papers by Ivo Nnane Breakdown of academic impact, for papers by Crescent R. Isham Breakdown of academic impact, for papers by Hong Yuen Wong Breakdown of academic impact, for papers by Alison D. Findlay Breakdown of academic impact, for papers by Kaori Endo‐Umeda
Rankless by CCL
2026